Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-22

Clinical Trial Update: Abacavir and Lamivudine PK in Children [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 study reports pharmacokinetics of abacavir and lamivudine in HIV-infected children; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)
  • Ziagen (Abacavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV | Phase 2, Phase 3 | Status: COMPLETED